http://rdf.ncbi.nlm.nih.gov/pubchem/patent/MX-PA05002699-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1fe84084eed7f266d099c2d96e0eab56 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-55 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-575 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-54 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-555 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-0005 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-04 |
| filingDate | 2003-09-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_749917f6bd1664419a3c5530b394b8f2 |
| publicationDate | 2005-09-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | MX-PA05002699-A |
| titleOfInvention | IMMUNIZATION AGAINST AUTOMATIC GRELINA. |
| abstract | The present invention relates to new methods that generally rely on immunization against autologous ghrelin. The immunization is preferably carried out by administration of autologous ghrelin analogs, said analogs are capable of inducing the production of antibody against autologous ghrelin polypeptides. Especially preferred as an immunogen is autologous ghrelin, which has been modified by the introduction of a single or some epitopes of immunodominant and promiscuous, foreign T cells. Also described are nucleic acid vaccinations against ghrelin and vaccination using live vaccines, as well as methods and means used for vaccination. Such methods and means include methods for the preparation of analogs and pharmaceutical formulations, as well as nucleic acid fragments, vectors, transformed cells, polypeptides and pharmaceutical formulations. |
| priorityDate | 2002-09-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 452.